Cookie Consent by FreePrivacyPolicy.com
genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

09.11.2023
Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York

read more
Latest News:

04.05.2023
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!

read more
  • LSX World conference

    Genekam is to attend LSX World conference 29-30 April, 2024, Business Design Center, London, UK

    read more
  • MEDICA 2024

    Visit us on Medica Duesseldorf, 11.-14. November 2024

    read more

Genekam has developed a number of therapeutic molecules for therapy of Ebola virus, Middle east Syndrome virus and Influenza virus (H1N1)

Genekam has developed a number of therapeutic molecules for therapy of Ebola virus, Middle east Syndrome virus and Influenza virus (H1N1)

02.07.2015
TOP